| Stone Characteristics | Outcomes | Complication | ||||||
---|---|---|---|---|---|---|---|---|---|
Stone Volume | Stone size (mm) | Density (HU) | Mean operative times | Laser on time (LOT) | Stone free rate | Ablation efficacy (J/mm3) | Ablation speed (mm3/sec) | ||
Delbarre et al. [10] | NR | 20.4 (17.3) | NR | 62 (25.5) |  | 72% | NR | NR | Clavien grade I–II (9), Clavien grade III–V (4) |
Singh A et al. [11] | 1753.12 ± 1245.81 (1169.27–2193.25) mm3 |  | 1104.46 ± 313.09 (875.00–1317.00) HU | 43.38 ± 12.96 (35.00–51.25) min | 537.79 ± 689.89 (21.00–1080.00) sec | NR | 20.30 ± 15.5 (8.88–25.57) J/mm3 | 1.32 ± 0.7 (0.82–1.64) mm3/sec | Clavien grades 1–2 |
Quiroz Madarriaga Y. et al. [12] | NR | 9.7 mm (4–19 mm) | NR | 55 min | NR | 90% | NR | NR | No complications |
Geavlete B. et al. [13] | NR | 13.25 ± 4.74 | 1045.1 ± 109.19 | 64.06 ± 15.01 | Nil | 96.61% | NR | NR | Haematuria, fever |
Soundarya G. et al. [14] | NR | 18.34 ± 3.06 mm | 1014.06 ± 244.82 HU | NR | 1242.69 ± 515.20 s | 88.40% | Mean laser efficacy:9.37  ± 4.17 | 1.80 ± 0.63 mm3 /sec | No complication more than Grade 2 occurred, hematuria, fever, and transient rise in serum creatinine |
Sytnik D. et al. [15] | NR | on the right—12 mm ± 2.6 mm; on the left—11.7 mm ± 2.4 mm) | 1134 ± 217 HU | 56 ± 11 | Nil | 83.3% | NR | NR | Increased body temperature (one patient) (Clavien-Dindo II) |
Taraktin M. et al. [4] | 279.6(139.4–615.8) | 12.5 ± 8.8 (7–30) | 1020 ± 382(250–1900) | NR | 2.7(1.6–6.6) | 89% | 13.3 (7.3–20.9) | 1.7 (1.0–2.8) | Fever, Transient creatinine elevation, Urinary tract infection |
Vaddi C.M. et al. [16] | 1061.85 ± 806.81 mm3 | 15.19 ± 4.52 | 985.82 ± 302.57 | NR | 19.78 ± 12.32 | 93.60% | Mean laser efficacy: 14.35 ± 5.70 | 0.86 ± 0.31 | Haematuria, fever, Clavien grades 1–2 |
Sierra et al. [17] | ureteral: 486 (332–1250) mm3, renal: 1800 (682.8–2760) mm3 | ureteral: 347 (147–1800) mm3 renal:1125 (294–4000) mm3 | ureteral stones 998 (776–1300) HU; renal stones 1200 (750–1300) HU | NR | 23 (14.2–38.7) | 100% | ureteral;8.7 (4.8–65.2); renal:14.3 (7.8–24.7) | ureteral:0.3 (0.2–1.3); renal:0.7 (0.4–1.2) | Clavien grades 2 |
Taraktin M. et al. [18] | 2743 (1451–4213) | 23.5 ± 6.3 (20–36) | 833.8 ± 298.3 (400–1394) | NR | 11.7 (10.0–15.5) | 85.70% | 4.6 (2.9–5.5) | 3.9 (3.9–5.7) | Fever, Transient creatine elevation |
Enikeev D. et al. [19] | 883 (606–1664) mm3 | 883 (IQR 606–1664) mm3 | 880 ± 381 HU | 23.1 ± 10.9 | G1: 0.5 J × 30 Hz 15 W; G2: 372 (96–414) | 92.50% | G1:2.7 (1.8–9.8); G2:4.8 (2.6–11.3) | G1:5.5 (1.5–8.7) G2:8.5 (3.6–19.0) | Clavien 1–2 |
Korolev D. et al. [20] | 1st stone:1,531.8 (5,592.2); 2nd stone: 690.4 (1,606.6); 3rd stone: 561.1 (977.4) |  | 900.7 (370.6), 862.0 (373.7), 634.1 (399.6) | 59.4 ± 31.5 | NR | NR | NR | NR | Postoperative bleeding (1), fever (1), pain (2), sepsis (3), stent loss (1) |